Prachi S. Vilekar, Ph.D.
Affiliations: | 2012 | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Pharmacy, ImmunologyGoogle:
"Prachi Vilekar"Parents
Sign in to add mentor| Vibhudutta Awasthi | grad student | 2012 | University of Oklahoma Health Sciences Center | |
| (Anti-inflammatory effects of curcuminoid EF24.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Z, Wang Y, Vilekar P, et al. (2020) Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. Peerj. 8: e9533 |
| Awasthi V, Vilekar P, Rao G, et al. (2019) Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells. Immunobiology |
| Awasthi S, Vilekar P, Conkleton A, et al. (2019) Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response. Vaccine |
| Vilekar P, Rao G, Awasthi S, et al. (2015) Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells. Journal of Inflammation (London, England). 12: 55 |
| Yadav VR, Vilekar P, Awasthi S, et al. (2014) Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock Artificial Organs. 38: 675-683 |
| Vilekar P, King C, Lagisetty P, et al. (2014) Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA). Applied Biochemistry and Biotechnology. 172: 3363-73 |
| Vilekar P, Awasthi S, Natarajan A, et al. (2012) EF24 suppresses maturation and inflammatory response in dendritic cells. International Immunology. 24: 455-64 |
| Vilekar P, Awasthi V, Lagisetty P, et al. (2010) In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine. Bmc Immunology. 11: 60 |
| Lagisetty P, Vilekar P, Sahoo K, et al. (2010) CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones. Bioorganic & Medicinal Chemistry. 18: 6109-20 |
| Jayaraj R, Piedrafita D, Dynon K, et al. (2010) Vaccination and immunotherapy against bacteria, fungi and parasites (WS-048) Chairpersons: Hajime Hisaeda, Miodrag Colic International Immunology. 22 |